key: cord-0717861-0dyznjdt
authors: Perečinský, Slavomír; Donič, Viliam; Legáth, Ľubomír
title: Partially ionized medical oxygen as a supplementary treatment for COVID-19
date: 2020-07-30
journal: Wien Klin Wochenschr
DOI: 10.1007/s00508-020-01717-7
sha: 1a944b4d303def831daf18bdb69d31970ff5c435
doc_id: 717861
cord_uid: 0dyznjdt

nan

Ivan Engler, MD, PhD. from Salzburg. Partially ionized oxygen (O2 -, O2 + ) can be produced by ionization of medical oxygen (O2) in the high-voltage chamber of the Oxygen Ion 3000/Dr. Engler device. The device has been commercially available since 2000 and is produced by CS Tronic (St Pantaleon, Austria) as a medical device with EU certification. It is commonly used for the treatment of bronchial asthma [2] . The benefit of this method was also confirmed in other diagnoses [3, 4] The effect of O2is similar to O3: O2is a very potent free oxygen radical, which induces direct inactivation of the virus through oxidation of the membrane glycoproteins. Compared to ozone it has one significant advantage. Ozone is highly irritating to the lungs and cannot be inhaled. Therefore, it is most commonly administered by direct intravenous application [5] . On the other hand, oxygen ions, both positive and negative, can be safely inhaled. Additionally, oxygen therapy is essential for severe cases of COVID-19 [6] . A different view on management of COVID-19 is to decrease the adverse effect of long-term oxygen therapy. Hyperoxia induces lung injury resulting from direct oxygen toxicity and the accumulation of inflammatory cells and mediators within the lungs [7] . In vitro study confirmed that long-term inhalation of partially positively ionized oxygen (O2 + ) was associated with less oxidative stress, better ability to secure airway patency and milder lung inflammatory response than molecular oxygen. Another promising result was a lower degree of lung desiccation in animals with positively and negatively ionized oxygen in comparison to molecular oxygen. There is no need for humidification of inhaled partially ionized oxygen [8] . The similar benefit of O2 + was found even in myocardial and brain cells of guinea pigs [9, 10] .

The main limitation of this method is the need for a special medical device which means it is not ap-plicable outside hospital conditions. Secondly, at the moment the effective time of inhalation O2for virus inactivation has not yet been estimated.

However, we believe that partially ionizing oxygen therapy will be a useful supplementary treatment of COVID-19, especially in lung damage protection.

A plausible "penny" costing effective treatment for corona virus-ozone therapy

Effects of ionized waterfall aerosol on pediatric allergic asthma

Effect of partially ionized medical oxygen, especially O2 -• in vibration white finger patients

Pulmonaryarterialhypertension influenced by inhalation of partially negative ionized oxygen (O2•)

Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: areviewof currentknowledgeandexperience

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected

Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells

Differences in oxidative status, lung function, and pulmonary surfactant during long-term inhalation of medical oxygen and partially ionized oxygen in guinea pigs

Effects of long-term oxygenation treatments on a-ketoglutarate dehydrogenase activity and oxidative modifications in mitochondria of guinea pig heart

Effect of long-term normobaric hyperoxia on oxidative stress in mitochondria of the guinea pig brain

Conflict of interest S. Perečinský, V. Donič and L'. Legáth declare that they have no competing interests.